# OnCo record crg-023 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/crg-023/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "crg-023" ;
  schema:name "CRG-023"@en ;
  schema:description "CRG-023 is an experimental autologous tri-specific CAR T-cell therapy from CARGO Therapeutics, in preclinical development for large B-cell lymphoma; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/crg-023/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1966494/000095017025066940/crgx-20250331.htm>, <https://www.sec.gov/Archives/edgar/data/1966494/000095017025066940/crgx-20250331.htm> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Autologous tri-specific CAR T-cell therapy" ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd20/>, <https://onco.cc/targets/cd22/> ;
  onco:companies <https://onco.cc/companies/cargo-therapeutics/> .